ZR2 Bioenergy Limited (BOM:506640)
India
· Delayed Price · Currency is INR 152.00
+1.00 (0.66%)
At close: Apr 28, 2026
ZR2 Bioenergy Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | - | 14.95 | 15.74 | - | 11.56 | - | Upgrade
|
| Other Revenue | 0.2 | 0.2 | - | - | 0 | - | Upgrade
|
| Revenue | 0.2 | 15.15 | 15.74 | - | 11.56 | - | Upgrade
|
| Revenue Growth (YoY) | -99.34% | -3.75% | - | - | - | - | Upgrade
|
| Cost of Revenue | 1.59 | 12.95 | 13.22 | - | 9 | - | Upgrade
|
| Gross Profit | -1.39 | 2.2 | 2.51 | - | 2.56 | - | Upgrade
|
| Selling, General & Admin | 2.67 | 1.92 | 0.17 | 0.75 | 1.25 | 0.84 | Upgrade
|
| Other Operating Expenses | 1.29 | 2.91 | 1.18 | 0.22 | 0.82 | 0.48 | Upgrade
|
| Operating Expenses | 6.03 | 5.26 | 1.37 | 0.99 | 2.1 | 1.35 | Upgrade
|
| Operating Income | -7.42 | -3.06 | 1.15 | -0.99 | 0.45 | -1.35 | Upgrade
|
| Interest Expense | -0.01 | -0 | -1.94 | -0.14 | -0 | - | Upgrade
|
| Interest & Investment Income | 4.9 | 4.9 | 2.39 | 1.65 | 2.75 | 2.26 | Upgrade
|
| Other Non Operating Income (Expenses) | 12.36 | - | - | 0.03 | -0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | 9.83 | 1.84 | 1.6 | 0.55 | 3.19 | 0.92 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.18 | 0.18 | 0.75 | -0.23 | 0 | -0 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 1.46 | - | - | - | Upgrade
|
| Pretax Income | 10.01 | 2.02 | 3.81 | 0.33 | 3.2 | 0.92 | Upgrade
|
| Income Tax Expense | 0.82 | 1.12 | -0.08 | -0.03 | -0.73 | - | Upgrade
|
| Net Income | 9.19 | 0.9 | 3.89 | 0.36 | 3.92 | 0.92 | Upgrade
|
| Net Income to Common | 9.19 | 0.9 | 3.89 | 0.36 | 3.92 | 0.92 | Upgrade
|
| Net Income Growth | - | -76.82% | 986.76% | -90.87% | 326.57% | - | Upgrade
|
| Shares Outstanding (Basic) | 3 | 4 | 3 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 71 | 42 | 3 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 1759.44% | 1231.40% | 94.13% | - | - | - | Upgrade
|
| EPS (Basic) | 2.73 | 0.25 | 1.24 | 0.22 | 2.42 | 0.57 | Upgrade
|
| EPS (Diluted) | 0.13 | 0.02 | 1.24 | 0.22 | 2.42 | 0.57 | Upgrade
|
| EPS Growth | - | -98.39% | 462.92% | -90.92% | 326.54% | - | Upgrade
|
| Free Cash Flow | - | -884.4 | -201.93 | -113.45 | 9.05 | 2.55 | Upgrade
|
| Free Cash Flow Per Share | - | -21.14 | -64.25 | -70.08 | 5.59 | 1.57 | Upgrade
|
| Dividend Per Share | - | 0.100 | - | - | - | - | Upgrade
|
| Gross Margin | - | 14.52% | 15.97% | - | 22.12% | - | Upgrade
|
| Operating Margin | -3691.04% | -20.21% | 7.28% | - | 3.90% | - | Upgrade
|
| Profit Margin | 4570.15% | 5.96% | 24.73% | - | 33.93% | - | Upgrade
|
| Free Cash Flow Margin | - | -5839.19% | -1283.17% | - | 78.33% | - | Upgrade
|
| EBITDA | -6.67 | -2.63 | 1.16 | -0.97 | 0.48 | -1.32 | Upgrade
|
| EBITDA Margin | - | -17.34% | 7.37% | - | 4.15% | - | Upgrade
|
| D&A For EBITDA | 0.75 | 0.44 | 0.01 | 0.02 | 0.03 | 0.03 | Upgrade
|
| EBIT | -7.42 | -3.06 | 1.15 | -0.99 | 0.45 | -1.35 | Upgrade
|
| EBIT Margin | - | -20.21% | 7.28% | - | 3.90% | - | Upgrade
|
| Effective Tax Rate | 8.22% | 55.32% | - | - | - | - | Upgrade
|
| Revenue as Reported | 18.78 | 21.37 | 18.88 | 2.88 | 14.3 | 2.27 | Upgrade
|
| Advertising Expenses | - | 0.11 | 0.04 | 0.02 | 0.04 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.